Your session is about to expire
← Back to Search
Brain Stimulation for Schizophrenia
Study Summary
This trial is studying how well transcranial direct current stimulation (tDCS) works in improving higher-order cognition in people with and without schizophrenia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have vision problems that would make it difficult for you to complete cognitive tests. This includes color blindness if the test requires the ability to see different colors.You are pregnant.You have skin damage, such as eczema, where the electrodes will be placed.You have been diagnosed with schizophrenia, schizophreniform or schizoaffective disorder.You have implanted devices that use electricity to stimulate your brain or spine.You have a device called a defibrillator implanted in your body.You have metal implants in your body.You have a problem with your brain.You have had a head injury.You have epilepsy.You have a history of neurological disorders such as epilepsy, ALS, MS, stroke, cerebral palsy, or any psychiatric disorder listed in DSM-5 (for healthy control subjects), or autism.You have been addicted to drugs or alcohol within the last six months.You have a pacemaker.You have used drugs or alcohol in the last month.You have a developmental disability that affects intellectual functioning.You have been stable for at least 3 months.You have no medication changes in the prior month.
- Group 1: DLPFC Stimulation
- Group 2: Sham Stimulation
- Group 3: Occipital Stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the eligibility requirements for participating in this trial?
"This clinical trial can accept up to 120 individuals aged between 18 and 35 that have been diagnosed with schizophrenia. To be eligible, they must not plan on altering their medication in the upcoming month, are not using clozapine as an antipsychotic drug, remain stable while being treated either partially or out-patiently, and had no changes in medications during the past month."
What is the uppermost participant limit for this clinical trial?
"Confirmed. Clinicaltrials.gov outlines the commencement date of this study on May 22nd 2019, with a recent edit to the trial posted on January 25th 2022. The research is seeking 120 clinical participants from one centre."
Is eligibility for this experiment restricted to individuals younger than 55 years old?
"As listed in the study's inclusion criteria, only individuals between 18 and 35 years old are eligible to participate."
Are there still opportunities to join this research experiment?
"Per the information accessible on clinicaltrials.gov, this trial is currently recruiting suitable participants. It was originally posted to the website on May 22nd 2019 and last updated on January 25th 2022."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger